武汉85例COVID-19死亡病例的临床特征:回顾性观察研究
该研究回顾性收集2020年1月9日至2月15日武汉两家医院85例COVID-19死亡病例的医疗记录,描述其临床特征。患者中位年龄65.8岁,72.9%为男性,常见症状为发热、气短、乏力及呼吸困难,多数死于多器官衰竭。气短早发或可提示病情恶化,嗜酸性粒细胞减少或提示预后不良,联合抗菌药物未见明显获益。
要点
- 死亡病例以50岁以上男性及合并慢性非传染性疾病者为主。
- 气短早发可作为观察COVID-19病情加重的症状指标。
- 嗜酸性粒细胞减少可能提示预后不良。
核心结论
- 85例COVID-19死亡病例多数为50岁以上男性且合并慢性非传染性疾病,多数死于多器官衰竭。
研究设计与样本
- 回顾性观察研究,收集2020年1月9日至2月15日武汉两家医院85例COVID-19死亡病例的医疗记录。
主要发现
- 患者中位年龄65.8岁,72.9%为男性。
- 常见症状为发热78例(91.8%)、气短50例(58.8%)、乏力50例(58.8%)、呼吸困难60例(70.6%)。
- 81.2%患者入院时嗜酸性粒细胞计数很低。
- 并发症包括呼吸衰竭80例(94.1%)、休克69例(81.2%)、急性呼吸窘迫综合征63例(74.1%)、心律失常51例(60%)。
- 多数患者接受抗生素77例(90.6%)、抗病毒药物78例(91.8%)及糖皮质激素65例(76.5%)治疗。
临床怎么用
- 对COVID-19患者应关注气短早发表现,警惕病情加重。
- 入院嗜酸性粒细胞减少可作为预后不良的提示指标。
- 联合抗菌药物对该组患者结局未见明显获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: The global death toll from coronavirus disease (COVID-19) virus as of May 12, 2020, exceeds 286,000. The risk factors for death were attributed to advanced age and comorbidities but have not been accurately defined.Objectives: To report the clinical features of 85 fatal cases of COVID-19 in two hospitals in Wuhan.Methods: Medical records were collected of 85 fatal cases of COVID-19 between January 9, 2020, and February 15, 2020. Information recorded included medical history, exposure history, comorbidities, symptoms, signs, laboratory findings, computed tomographic scans, and clinical management.Measurements and Main Results: The median age of the patients was 65.8 years, and 72.9% were male. Common symptoms were fever (78 [91.8%]), shortness of breath (50 [58.8%]), fatigue (50 [58.8%]), and dyspnea (60 [70.6%]). Hypertension, diabetes, and coronary heart disease were the most common comorbidities. Notably, 81.2% of patients had very low eosinophil counts on admission. Complications included respiratory failure (80 [94.1%]), shock (69 [81.2%]), acute respiratory distress syndrome (63 [74.1%]), and arrhythmia (51 [60%]), among others. Most patients received antibiotic (77 [90.6%]), antiviral (78 [91.8%]), and glucocorticoid (65 [76.5%]) treatments. A total of 38 (44.7%) and 33 (38.8%) patients received intravenous immunoglobulin and IFN-α2b, respectively.Conclusions: In this depictive study of 85 fatal cases of COVID-19, most cases were males aged over 50 years with noncommunicable chronic diseases. The majority of the patients died of multiple organ failure. Early onset of shortness of breath may be used as an observational symptom for COVID-19 exacerbations. Eosinophilopenia may indicate a poor prognosis. A combination of antimicrobial drugs did not offer considerable benefit to the outcome of this group of patients.
引用
- Du Y, Tu L, Zhu P, et al. Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study. Am J Respir Crit Care Med. 2020. PMID: 32242738. doi:10.1164/rccm.202003-0543OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。